GGrantIndex
← Leaderboards

Meredith A Hawkins

Virginia Commonwealth University

$11,134,240
Attributed
$12,981,963
Total exposure
28
Grants
21
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.4M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$12,981,963 · 28

By mechanism

R01$10,847,294 · 3
M01$1,031,162 · 19
P01$869,450 · 2
R56$167,000 · 1
R25$36,476 · 1
P30$30,581 · 2

Top collaborators

Most similar at Virginia Commonwealth University

Same institution · by research overlap

Others in their field

Top investigators on “Insulin

Research focus

InsulinGlucosePlayNon-DiabeticSourceGlycemic ControlBlood Glucose RegulationGlucose ProductionHepaticSignal TransductionPreventChronicHyperglycemiaDiabetes MellitusPancreasFastingRegulationDefectInfusion ProceduresMediatingRodentDiabeticRattusClinical Research

Grant awards (63)

Restoring Central Regulation of Glucose Production in Type 2 Diabetes$677,112
R01 · FY2025 · DK · contact PI
Restoring Central Regulation of Glucose Production in Type 2 Diabetes$664,628
R01 · FY2024 · DK · contact PI
Restoring Central Regulation of Glucose Production in Type 2 Diabetes$125,335
R01 · FY2024 · DK · contact PI
Restoring Central Regulation of Glucose Production in Type 2 Diabetes$699,257
R01 · FY2023 · DK · contact PI
Restoring Central Regulation of Glucose Production in Type 2 Diabetes$94,001
R01 · FY2023 · DK · contact PI
Restoring Central Regulation of Glucose Production in Type 2 Diabetes$705,944
R01 · FY2022 · DK · contact PI
Restoring Central Regulation of Glucose Production in Type 2 Diabetes$729,169
R01 · FY2021 · DK · contact PI
Enrichment Program$6,141
P30 · FY2019 · DK · contact PI
Enrichment Program$3,410
P30 · FY2018 · DK · contact PI
Enrichment Program$2,731
P30 · FY2018 · DK · contact PI
Mechanisms of hypoglycemia-associated authonomic failure$217,097
R01 · FY2017 · DK · contact PI
Mechanisms of Hypoglycemia-Associated Authonomic Failure$151,177
R01 · FY2017 · DK · contact PI
Mechanisms of hypoglycemia-associated authonomic failure$79,133
R01 · FY2017 · DK · contact PI
Enrichment Program$6,140
P30 · FY2017 · DK · contact PI
Regulation of hepatic glucose fluxes$553,838
R01 · FY2016 · DK · contact PI
Mechanisms of hypoglycemia-associated authonomic failure$368,273
R01 · FY2016 · DK · contact PI
Enrichment Program$6,141
P30 · FY2016 · DK · contact PI
Regulation of hepatic glucose fluxes$510,604
R01 · FY2015 · DK · contact PI
Mechanisms of hypoglycemia-associated authonomic failure$214,825
R01 · FY2015 · DK · contact PI
Mechanisms of hypoglycemia-associated authonomic failure$153,448
R01 · FY2015 · DK · contact PI
Regulation of hepatic glucose fluxes$46,419
R01 · FY2015 · DK · contact PI
Enrichment Program$3,460
P30 · FY2015 · DK · contact PI
Enrichment Program$2,558
P30 · FY2015 · DK · contact PI
Regulation of hepatic glucose fluxes$560,206
R01 · FY2014 · DK · contact PI
Mechanisms of hypoglycemia-associated authonomic failure$368,273
R01 · FY2014 · DK · contact PI
Regulation of hepatic glucose fluxes$563,391
R01 · FY2013 · DK · contact PI
Mechanisms of hypoglycemia-associated authonomic failure$368,273
R01 · FY2013 · DK · contact PI
Regulation of Hepatic Glucose Fluxes$167,000
R56 · FY2012 · DK · contact PI
Role of Hepatic Fat Metabolism in Glucose Effectiveness$320,584
R01 · FY2010 · DK · contact PI
Role of Hepatic Fat Metabolism in Glucose Effectiveness$323,823
R01 · FY2009 · DK · contact PI
Biochemical Mechanisms of In Vivo Insulin Resistance$455,437
R01 · FY2008 · DK · contact PI
Role of Hepatic Fat Metabolism in Glucose Effectiveness$323,823
R01 · FY2008 · DK · contact PI
CLINICAL TRIAL: INCYTE$38,744
M01 · FY2008 · RR · contact PI
HGP$24,816
M01 · FY2008 · RR · contact PI
DIAZOXIDEH$21,271
M01 · FY2008 · RR · contact PI
PPAR-ALPHA$8,356
M01 · FY2008 · RR · contact PI
GLUCOSAMINE$3,039
M01 · FY2008 · RR · contact PI
LEUCINE$253
M01 · FY2008 · RR · contact PI
Biochemical Mechanisms of In Vivo Insulin Resistance$451,304
R01 · FY2007 · DK · contact PI
Role of Hepatic Fat Metabolism in Glucose Effectiveness$330,431
R01 · FY2007 · DK · contact PI
CORE--ANIMAL PHYSIOLOGY$240,268
P01 · FY2007 · AG · contact PI
ROLE OF NUTRIENTS IN AGE-RELATED INSULIN RESISTANCE$233,736
P01 · FY2007 · AG · contact PI
PPAR-ALPHA$60,567
M01 · FY2007 · RR · contact PI
GLUCOSAMINE$53,269
M01 · FY2007 · RR · contact PI
HGP$32,108
M01 · FY2007 · RR · contact PI
DIAZOXIDEH$32,108
M01 · FY2007 · RR · contact PI
Biochemical Mechanisms of In Vivo Insulin Resistance$451,360
R01 · FY2006 · DK · contact PI
Role of Hepatic Fat Metabolism in Glucose Effectiveness$340,129
R01 · FY2006 · DK · contact PI
ROLE OF NUTRIENTS IN AGE-RELATED INSULIN RESISTANCE$221,524
P01 · FY2006 · AG · contact PI
CORE--ANIMAL PHYSIOLOGY$173,922
P01 · FY2006 · AG · contact PI
GLUCOSAMINE$72,918
M01 · FY2006 · RR · contact PI
PPAR-ALPHA$68,147
M01 · FY2006 · RR · contact PI
HGP$19,763
M01 · FY2006 · RR · contact PI
HGP$221,130
M01 · FY2005 · RR
GLUCOSAMINE$72,668
M01 · FY2005 · RR
PPAR-ALPHA$22,661
M01 · FY2005 · RR
HGP$225,026
M01 · FY2004 · RR
GLUCOSAMINE$39,769
M01 · FY2004 · RR
PPAR-ALPHA$14,549
M01 · FY2004 · RR
EFFECT OF HYPERGLYCEMIA PER SE ON HEPATIC GLUCOSE FLUXES IN NIDDM$0
M01 · FY2001 · RR
THE ROLE OF GLUCOSAMINE PATHWAY IN NUTRITIONALLY-MEDIATE$36,476
R25 · FY2000 · RR
HYPERGLYCEMIA--HEPATIC GLUCOSE FLUXES IN DIABETES$0
M01 · FY2000 · RR
EFFECT OF HYPERGLYCEMIA PER SE ON HEPATIC GLUCOSE FLUXES IN NIDDM$0
M01 · FY2000 · RR